Bio-M AG Bio-M is a financing service and consulting company with the aim to promote the development of the BioTech-Region München. It is the “one-stop shop” for start-up biotech companies seeking financial support, business advice and the right contacts. Bio-M has set up a finance program to provide promising biotechnology companies with venture capital in the initial seed and start-up phases. |
 |
BioTOP BioTOP Berlin Brandenburg is the central contact and coordination office for all issues concerning biotechnology in the German capital region. It is our objective to coordinate all regional activities in biotechnology by networking with all key players and to initiate specific projects in order to turn Berlin-Brandenburg into a globally leading life science cluster. The services provided by BioTOP include:
For more information, including a database with comprehensive profiles of all companies and scientific work groups, please visit our website at www.biotop.de |
 |
Citigate Dewe Rogerson Citigate Dewe Rogerson (CDR) is the leading international consultancy specialising exclusively in financial and corporate communications across the UK, Europe, North America and Asia. CDR is a member of Huntsworth plc, the leading international communications group. With Headquarters based in London, Huntsworth plc operates out of 45 principal offices in 21 countries worldwide. The group has particular strengths in the consumer, financial, public affairs, integrated healthcare and technology sectors. CDR has a dedicated Pharma & Biotech team with more than 40 years combined experience in the sector and a unique mix of skills: corporate and financial PR and investor relations, finance, journalism and academic science. The team provides sector expertise and forms an integrated part of Citigate Dewe Rogerson, benefiting from CDR’s overall strength and from the cross-fertilisation of ideas across sectors. The CDR Pharma & Biotech team has an established track record in working with biotechnology companies at all stages in development. As well as core skills in financial calendar work, transactions support, financial PR and media relations, the team has extensive experience in branding, design and new media consultancy. Recent clients include global top-five biotechs, listed companies in the UK and Europe, and numerous emerging businesses in the UK, France, Germany, the Netherlands, and Scandinavia. |
 |
GoingPublic Media AG Founded in 1998 GoingPublic Media AG is today one of the leading publishing companies in Germany for magazines regarding private equity/venture capital, corporate finance, technology and investment. In addition to the monthly issued GoingPublic Magazin with a 8 years publishing history and its well known yearly special editions like “Corporate Finance & Private Equity Guide” or “Biotechnology” among others, which are largely meant as reference books, the company publishes the also monthly issued VentureCapital Magazin, founded in 2000. Nowadays the VentureCapital Magazin stands as a hub for the private equity and venture capital industry in German speaking Europe and addresses investors and entrepreneurs who focus on private equity, buy-outs and M&A. The 2003 established Smart Investor Magazin* is a monthly publication for “sophisticated” retail investors. The quarterly published “HV Magazin” focuses on organizational, technical und legal trends concerning the annual shareholder meeting and is targeted to CFOs, investor relations managers and advisory board members. The corporate publishing division (“GoingPublic Services”) publishes about 10 magazines and newsletters a year for well-known venture capital companies and financial institutions.All publications are published in German. Contact: Tel.: (0049) 08171-4196-50
|
 |
Kirchhoff Consult Kirchhoff Consult is a consulting company and design agency. We are specialized in equity consulting, financial communication and corporate communication. We are leaders in capital market transactions and annual reports. We advise our clients with teams in Germany, Switzerland and Austria. In UK/USA we co-operate with specialized partners. Our clients benefit from more than 15 years of experience in capital markets. Our interdisciplinary teams consist of Investor Relations Officers, Journalists, Corporate Finance advisers, Financial Analysts, Communication Consultants and Art Directors. Among our references are companies like Allianz, Bayer, BMW, EIC Electricity, Fraport, Hero, Jelmoli, Lanxess, MAN, MediGene, Nobel Biocare, Phoenix Mecano, Wincor Nixdorf, Züblin Immobilien Holding AG. Our services comprise: |
 |
Northbank Communications Northbank Communications is a full service communications consultancy focused on science-based companies. We believe that these companies perhaps more than most, need high quality communications to build corporate value and promote their leading edge products, technologies and services. Northbank has offices in London, Congleton (near Manchester) and Munich. We provide expert counsel to our clients through a range of specialist business consulting, communications and design services appropriate to their needs. We also offer outreach programmes to media, industry, public, financial and investment communities. We provide ongoing support through all stages of a company’s development – from start-up or early stage, through listing and beyond as a publicly quoted company. In addition, we can assist publicly funded organisations and initiatives. Our understanding of the technical, commercial and financial issues facing our clients, alongside the expertise of our team and broad network of contacts, means we are able to offer a personalised, highly effective and value for money service. |
 |
The Trout Group From our headquarters in New York and our offices in Boston and San Francisco, Trout’s team of professionals serves 40 clients from seven countries. Trout’s suite of services centers
on an active investor relations program, while providing access
to and enhancing relationships with the investment community,
including: The Trout Group. Relationship Capital. |
Venture Valuations Venture Valuation specializes in independent, third party assessment, valuation and monitoring of biotechnology and life sciences companies. The services are provided in the form of independent reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Zurich, Munich and North America, Venture Valuation comprises experts in finance, biotechnology, pharma. Services
Clients |
WOCP – Worldwide Organisation for Collaborations in the Pharmaceutical Industry The Worldwide Organization for Collaborations in the Pharmaceutical Industry is dedicated to supporting collaborative arrangements in the Pharma and Biotech Industry. W.O.C.P. was set up in response to the need in the industry for collaborations, including commercial transactions related to marketed products, such as co-promotion arrangements, expansion in new geographical territories, or product divestments or acquisitions, development compound alliances and partnering arrangements such as licensing, research collaborations, technology transfer deals (including university and academic institution - industry collaborations), as well as corporate transactions (e.g. M&A and strategic alliances). W.O.C.P.’s remit is to facilitate partnering in the industry, collect, help develop and disseminate knowledge about best practices in dealmaking, improve communication and increase exposure of its members and the industry and widen the collaboration possibilities of its members around the world. W.O.C.P.’s member benefits include a unique exposure to thousands of companies around the World and the executives that specialize in managing deals in their companies, the inclusion of detailed Corporate Overviews of every member organization and individual, a database of partnering opportunities that is set to grow (accessible to all, without limitation) as well as career advancement opportunities. For more information, please visit www.wocp.org |
 |